0 Comentários
0 Compartilhamentos
213 Visualizações
0 Anterior
Pesquisar
Conheça novas pessoas, crie conexões e faça novos amigos
-
Faça Login para curtir, compartilhar e comentar!
-
Breast Cancer Immunotherapy Market – Precision Immune Approaches Reshaping Oncology CareMarket Overview The breast cancer immunotherapy market is expanding rapidly as checkpoint inhibitors, antibody-drug conjugates, and emerging cellular therapies move beyond triple-negative subtypes into broader clinical use. Oncologists increasingly incorporate immune-based approaches alongside chemotherapy and targeted agents, reflecting a shift toward personalized treatment strategies guided...0 Comentários 0 Compartilhamentos 227 Visualizações 0 Anterior
-
Circulating Tumor Cells Cancer Stem Cells Market – Liquid Biopsy Innovation Advancing Precision OncologyMarket Overview The circulating tumor cells cancer stem cells market is expanding as liquid biopsy technology gains traction for non-invasive cancer detection, monitoring, and treatment response assessment. By isolating and analyzing rare tumor cells circulating in a patient's bloodstream, clinicians can gather valuable information about cancer progression without invasive tissue biopsies....0 Comentários 0 Compartilhamentos 149 Visualizações 0 Anterior
-
Could Precision Oncology Advance the Topoisomerase Inhibitors MarketAccording to the latest report published by Data Bridge Market Research, the Topoisomerase Inhibitors Market CAGR Value The global topoisomerase inhibitors market size was valued at USD 5.49 billion in 2025 and is expected to reach USD 8.17 billion by 2033, at a CAGR of 5.10% during the forecast period Salient attributes used while forming an influential Topoisomerase Inhibitors...0 Comentários 0 Compartilhamentos 230 Visualizações 0 Anterior
-
Cyclin Dependent Kinase Inhibitor Market – Precision Oncology Advancing Through Targeted Cell Cycle TherapyMarket Overview The cyclin dependent kinase inhibitor market is expanding rapidly as oncology shifts toward precision therapies that halt uncontrolled cell division at its source. These inhibitors block specific enzymes responsible for driving the cell cycle in cancer cells, particularly in breast cancer and other hormone-receptor-positive malignancies. Growth is fueled by rising cancer...0 Comentários 0 Compartilhamentos 185 Visualizações 0 Anterior
-
Gene Panel Market – Powering Precision Diagnostics in Oncology and BeyondThe gene panel market sits at the core of precision diagnostics, enabling simultaneous analysis of multiple genes linked to specific diseases. It is a critical enabler of targeted therapy selection, risk assessment, and increasingly, population‑level screening strategies. The market was valued at approximately USD 6.8 billion in 2023, around USD 7.67 billion in 2024, and is projected to reach...0 Comentários 0 Compartilhamentos 226 Visualizações 0 Anterior
-
Global Post-CDK4/6 Treatment Line Oncology Drugs Market Report: Precision Oncology, Treatment Innovation and Growth ProspectsAccording to the latest report published by Data Bridge Market Research, the Post-CDK4/6 Treatment Line Oncology Drugs Market CAGR Value The global post-CDK4/6 treatment line oncology drugs market size was valued at USD 3.53 billion in 2025 and is expected to reach USD 10.06 billion by 2033, at a CAGR of 14.00% during the forecast period The...0 Comentários 0 Compartilhamentos 186 Visualizações 0 Anterior
-
How Histone Deacetylase 1 Research Is Advancing Epigenetic Therapies, Precision Oncology, and Drug DiscoveryThe histone deacetylase 1 market is expanding as pharmaceutical companies and research institutions increase investment in epigenetic science, cancer research, neurodegenerative disease studies, and precision medicine. The market was valued at USD 1.04 billion in 2024 and is projected to reach USD 2.5 billion by 2035, growing at a CAGR of 8.3%. 1216 The Histone Deacetylase 1 Market includes...0 Comentários 0 Compartilhamentos 122 Visualizações 0 Anterior
-
Liquid Biopsy Market to Reach USD 29.2 Billion by 2036 as Precision Oncology and Non-Invasive Cancer Testing Drive Global GrowthThe global Liquid Biopsy Market is poised for substantial expansion as healthcare providers increasingly adopt minimally invasive cancer diagnostic technologies for early detection, treatment monitoring, and personalized medicine. According to the latest industry analysis, the global Liquid Biopsy Market is projected to grow from USD 7.3 billion in 2026 to USD 29.2 billion by 2036, registering...0 Comentários 0 Compartilhamentos 267 Visualizações 0 Anterior
-
Metastatic Spinal Tumor Market – Precision Oncology and Advanced Imaging Support GrowthThe metastatic spinal tumor market is growing as cancer incidence rises, patient awareness improves, and healthcare providers adopt more advanced diagnostic and therapeutic approaches. The market was valued at USD 1.95 billion in 2024 and is projected to reach USD 3.5 billion by 2035, at a CAGR of 5.4%.wiseguyreports Metastatic spinal tumors can develop when cancer from another site spreads to...0 Comentários 0 Compartilhamentos 170 Visualizações 0 Anterior
-
Molecular Cancer Diagnostics: Advancing Precision Oncology for Pancreatic CancerMolecular cancer diagnostics have revolutionized the management of pancreatic cancer, offering a more precise and personalized approach to diagnosis and treatment. Molecular cancer diagnostics utilize advanced technologies to detect pancreatic cancer biomarkers, enabling precision oncology testing that guides targeted therapies. The global market for these diagnostics is projected to...0 Comentários 0 Compartilhamentos 164 Visualizações 0 Anterior
-
Nanobody Market – Targeted Cancer Therapies Advancing Precision OncologyMarket Overview Precision oncology is changing how researchers and clinicians approach cancer treatment. Rather than relying only on broad therapies, drug developers increasingly seek molecules that can recognize defined disease targets and deliver more focused therapeutic effects. Nanobodies are small antibody fragments derived from the unique antibodies found in camelids. Their compact size,...0 Comentários 0 Compartilhamentos 164 Visualizações 0 Anterior
-
DNA Sequencing Market: Global Demand & Industry Outlook 2033DNA Sequencing Market: Growth, Trends, Demand & Forecast to 2033 The DNA Sequencing Market is experiencing strong growth as sequencing technologies become more affordable, accurate, and scalable. The declining cost of sequencing, expanding applications in precision medicine and oncology, increasing genomic research, and technological advancements in high-throughput sequencing are...0 Comentários 0 Compartilhamentos 813 Visualizações 0 Anterior
-
Epidermal Growth Factor Receptor Inhibitor Market Growth Drivers and Investment OpportunitiesThe global Epidermal Growth Factor Receptor (EGFR) inhibitor industry is witnessing substantial momentum due to the increasing prevalence of cancer, growing adoption of targeted therapies, and advancements in precision medicine. The Epidermal Growth Factor Receptor Inhibitor Market size is expected to reach US$ 32.14 Billion by 2034 from US$ 15.92 Billion in 2025. The market is estimated to...0 Comentários 0 Compartilhamentos 1K Visualizações 0 Anterior
-
Global Dual-Antibody ADC Market Growing at 6.2% CAGR Through 2032According to a new report from Intel Market Research, the global Dual-Antibody ADC market was valued at USD 477 million in 2024 and is projected to reach USD 691 million by 2032, exhibiting a steady CAGR of 6.2% during the forecast period (2025–2032). This growth is driven by increasing cancer prevalence and demand for precision medicine, superior tumor targeting capabilities of...0 Comentários 0 Compartilhamentos 790 Visualizações 0 Anterior
-
HDAC Inhibitor Market Segmentation Analysis by Indication and End UserThe global HDAC inhibitor market is gaining significant momentum as the healthcare industry continues to advance targeted therapies for cancer and other complex diseases. Histone deacetylase (HDAC) inhibitors are a class of compounds that regulate gene expression by altering chromatin structure, making them valuable in the treatment of various malignancies and epigenetic disorders. The...0 Comentários 0 Compartilhamentos 1K Visualizações 0 Anterior
-
Precision Cancer Diagnostic Tests Market Advancements Improving Cancer Survival RatesThe global precision cancer diagnostic tests market is witnessing remarkable growth due to the increasing demand for personalized medicine, advancements in molecular diagnostics, and rising cancer prevalence worldwide. Precision cancer diagnostics play a critical role in identifying genetic mutations, biomarkers, and molecular characteristics of tumors, enabling healthcare providers to develop...0 Comentários 0 Compartilhamentos 1K Visualizações 0 Anterior
-
United States ADC for Solid Tumors Market Growing at 8.9% CAGR Through 2034The United States Antibody‑Drug Conjugate (ADC) for Solid Tumors market size was valued at approximately USD 0.55 billion in 2025. The market is projected to grow from approximately USD 0.58 billion in 2026 to around USD 1.04 billion by 2034, exhibiting a CAGR of about 8.9% during the forecast period. Antibody‑Drug Conjugates are targeted therapeutics that combine a monoclonal antibody that...0 Comentários 0 Compartilhamentos 1K Visualizações 0 Anterior
Páginas Impulsionadas
English
Arabic
French
Spanish
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek